Failure of antiepileptic drugs in controlling seizures in epilepsy: What do we do next?

被引:4
|
作者
Galindo-Mendez, Brahyan [1 ]
Mayor, Luis C. [2 ]
Velandia-Hurtado, Fernando [1 ]
Calderon-Ospina, Carlos [1 ]
机构
[1] Univ Rosario, Sch Med & Hlth Sci, Dept Basic Sci, Bogota, Colombia
[2] Univ Los Andes, Hosp Univ Fdn Santa Bogot, Fac Med, Bogota, Colombia
来源
EPILEPSY & BEHAVIOR CASE REPORTS | 2015年 / 4卷
关键词
Epilepsy; Malformations of cortical development; Cortical dysplasia-focal epilepsy syndrome; Anticonvulsants; Drug resistance;
D O I
10.1016/j.ebcr.2015.03.004
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Medically intractable epilepsy is a clinical condition of concern that arises when a patient with epilepsy suffers seizures, despite a trial of two or more antiepileptic drugs (AEDs) suitable for the type of epilepsy that are prescribed atmaximum tolerated doses, does not achieve control of seizures. This diagnosis could be related to cortical dysplasias. We report the case of a 5-year-old girl with a previous normal neurological development and no family history of epilepsy who presentedwith focal-type seizures at age 4. She started treatment by taking different AEDs for seizure control. She continued having frequent seizures that sometimes progressed to generalized seizures and status epilepticus. After a focal cortical resection performed in the area where interictal spikes were detected, the pathology confirmed a type IIb cortical dysplasia as the cause of the epilepsy. This article discusses cortical dysplasias as a cause of pharmacoresistant epilepsy and its treatment. (C) 2015 The Authors. Published by Elsevier Inc.
引用
收藏
页码:6 / 8
页数:3
相关论文
共 50 条
  • [21] Do no harm - But first we need to know more: The case of adverse drug reactions with antiepileptic drugs
    Singh, Gagandeep
    NEUROLOGY INDIA, 2011, 59 (01) : 53 - 58
  • [22] New advances in Traditional Chinese Medicine interventions for epilepsy: where are we and what do we know?
    Sun, Minjuan
    Qiu, Xiaoyun
    Yuan, Zhijian
    Xu, Cenglin
    Chen, Zhong
    CHINESE MEDICINE, 2025, 20 (01):
  • [23] Epilepsy audit: do we document everything?
    M. Iqbal
    S. Bilal
    S. Sarwar
    R. P. Murphy
    Irish Journal of Medical Science, 2011, 180 : 31 - 35
  • [24] Epilepsy audit: do we document everything?
    Iqbal, M.
    Bilal, S.
    Sarwar, S.
    Murphy, R. P.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2011, 180 (01) : 31 - 35
  • [25] Morningness and eveningness: When do patients take their antiepileptic drugs?
    Hofstra, Wytske A.
    Van der Palen, Job
    de Weerd, Al W.
    EPILEPSY & BEHAVIOR, 2012, 23 (03) : 320 - 323
  • [26] Genetics and antiepileptic-mood stabilizer treatment response in bipolar disorder: what do we know?
    Ho, Ada Man-Choi
    Weinshilboum, Richard M.
    Frye, Mark A.
    Biernacka, Joanna M.
    PHARMACOGENOMICS, 2021, 22 (14) : 913 - 925
  • [27] Epilepsy and pregnancy: What should the neurologists do?
    Dupont, S.
    Vercueil, L.
    REVUE NEUROLOGIQUE, 2021, 177 (03) : 168 - 179
  • [28] Temporal lobe epilepsy: Where do the seizures really begin?
    Bertram, Edward H.
    EPILEPSY & BEHAVIOR, 2009, 14 : 32 - 37
  • [29] Yoga and epilepsy: What do patients perceive?
    Naveen, G. H.
    Sinha, S.
    Girish, N.
    Taly, A. B.
    Varambally, S.
    Gangadhar, B. N.
    INDIAN JOURNAL OF PSYCHIATRY, 2013, 55 (07) : S390 - S393
  • [30] Do recent seizures and recent changes in antiepileptic drugs impact performances on neuropsychological tests in subtle ways that might easily be missed?
    Dodrill, Carl B.
    Ojemann, George A.
    EPILEPSIA, 2007, 48 (10) : 1833 - 1841